Profiel
Robert G.
L.
Shorr is the founder of AT Biochem, Inc., Cornerstone Pharmaceuticals, Inc., and several other companies.
He currently holds the position of Director-Business Development at Stony Brook University since 1998, Trustee at Imperial College London since 1999, and Trustee at Tissue Engineering Charities, Inc. since 1999.
Previously, he served as Director at BioDelivery Sciences International, Inc., Director at Brainstorm Cell Therapeutics, Inc. from 2011 to 2018, Associate Director at Smithkline & French Laboratories US, Inc. from 1988 to 1988, and President-Research & Development at Enzon Pharmaceuticals, Inc. He also held the position of Vice President-Science & Technology at United Therapeutics Corp.
in 2005.
Dr. Shorr obtained a doctorate degree from the University of London and an undergraduate degree from the State University of New York at Buffalo.
Actieve functies van Robert Shorr
| Bedrijven | Functie | Begin |
|---|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Oprichter | - |
Stony Brook University
Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1998 |
Tissue Engineering Charities, Inc. | Directeur/Bestuurslid | 16-05-2011 |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | 01-01-1999 |
Eerdere bekende functies van Robert Shorr
| Bedrijven | Functie | Einde |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Bestuurslid | 01-02-2018 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Bestuurslid | 28-04-2005 |
| UNITED THERAPEUTICS CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 |
Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 01-01-1988 |
AT Biochem, Inc. | Oprichter | - |
Opleiding van Robert Shorr
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University
Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Smithkline & French Laboratories US, Inc. | |
AT Biochem, Inc. | |
Tissue Engineering Charities, Inc. |
















